Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.25 -0.03 (-2.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sonoma Pharmaceuticals (SNOA) Liabilities and Shareholders Equity (2011 - 2026)

Updated

Sonoma Pharmaceuticals (SNOA) recorded Liabilities and Shareholders Equity of $18.11 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 24.1% from $14.59 million a year earlier and up 29.7% from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Sonoma Pharmaceuticals reported Liabilities and Shareholders Equity of $13.96 million, up 1.9% from FY2025.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of -1.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Liabilities and Shareholders Equity came in at $13.69 million in FY2025 (-7.1%), $14.74 million in FY2024 (-9.2%), $16.23 million in FY2023 (-13.9%) and $18.85 million in FY2022 (+25.7%).
  • The fiscal Q1 2027 figure is the highest quarterly Liabilities and Shareholders Equity since fiscal Q4 2022.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last eight quarters, with growth averaging 2.6%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 25.7% in fiscal Q4 2022, against a decline of 28.0% in fiscal Q3 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $13.96 million (Q4 2026), $13.62 million (Q3 2026) and $13.86 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 Sonoma Pharmaceuticals 4.92 Mn -8.41 Mn 2.58 Mn 18.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.11 Mn
Mar 31, 2026 13.96 Mn
Dec 31, 2025 13.62 Mn
Sep 30, 2025 13.86 Mn
Jun 30, 2025 14.59 Mn
Mar 31, 2025 13.69 Mn
Dec 31, 2024 13.67 Mn
Sep 30, 2024 13.69 Mn
Jun 30, 2024 13.67 Mn
Mar 31, 2024 14.74 Mn
Dec 31, 2023 14.62 Mn
Sep 30, 2023 13.64 Mn
Jun 30, 2023 15.89 Mn
Mar 31, 2023 16.23 Mn
Dec 31, 2022 13.93 Mn
Sep 30, 2022 14.96 Mn
Jun 30, 2022 17.16 Mn
Mar 31, 2022 18.85 Mn
Dec 31, 2021 19.35 Mn
Sep 30, 2021 19.83 Mn
API Access

Sonoma Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SNOA&period=max&api_key=YOUR_API_KEY